BioNTech

CompanyMainz, Germany· Biotech

German biotech company developing mRNA medicines.

Minutes holds 1 development naming BioNTech, recorded from October 2026.

Activity

BioNTech

BioNTech says its mRNA head and neck cancer therapy missed a trial objective

BioNTechBiotech13 OctBioPharma Dive

Elsewhere in Biotech

Past 3 months in Activity →

Biotech Rewind Therapeutics secures financing for oral remyelination program

Deal · FundingRewind TherapeuticsBiotech6 OctGlobeNewswire

Biotech Spyre Therapeutics launches public offering of its common stock

Deal · FundingSpyre TherapeuticsBiotech5 OctGlobeNewswire